Adma Biologics ADMA
NASDAQ ADMA
$10.03 +0.07 (+0.70%)
At close: Sep 30, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Long-Term Deferred Tax (2024 - 2026)

Updated

Adma Biologics' Long-Term Deferred Tax came in at $69.97 million for Q2 2026, down 11.7% from $79.24 million a year earlier and unchanged from the prior quarter.

Analysis

Adma Biologics (ADMA) Long-Term Deferred Tax (2024 - 2026) Analysis & Trends

At the end of FY2025, Adma Biologics' Long-Term Deferred Tax was $73.26 million, down 13.1% from FY2024.

  • Going back by year, Long-Term Deferred Tax was $84.28 million in FY2024.
  • Year-over-year, Long-Term Deferred Tax has declined for three consecutive quarters.
  • Business Quant data shows ADMA's Long-Term Deferred Tax at $69.97 million (Q1 2026), $73.26 million (Q4 2025) and $74.43 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Adma Biologics 2.26 Bn 1.84 Bn 86.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69.97 Mn
Mar 31, 2026 69.97 Mn
Dec 31, 2025 73.26 Mn
Sep 30, 2025 74.43 Mn
Jun 30, 2025 79.24 Mn
Mar 31, 2025 80.86 Mn
Dec 31, 2024 84.28 Mn
API Access

Adma Biologics Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=ADMA&period=max&api_key=YOUR_API_KEY